Terms: = Head and neck cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25
127 results:
1. Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma.
Seiwert TY; Wildsmith S; Fayette J; Harrington K; Gillison M; Ahn MJ; Takahashi S; Weiss J; Machiels JP; Baxi S; Baker V; Evans B; Morsli N; Jill Walker ; Real K; L'Hernault A; Psyrri A
Cancer Immunol Immunother; 2024 Mar; 73(4):70. PubMed ID: 38430375
[TBL] [Abstract] [Full Text] [Related]
2. VAV2 orchestrates the interplay between regenerative proliferation and ribogenesis in both keratinocytes and oral squamous cell carcinoma.
Fernández-Parejo N; Lorenzo-Martín LF; García-Pedrero JM; Rodrigo JP; Dosil M; Bustelo XR
Sci Rep; 2024 Feb; 14(1):4060. PubMed ID: 38374399
[TBL] [Abstract] [Full Text] [Related]
3. Interaction of Integrin αvβ8 With Type I Collagen Promotes Squamous Cell Carcinoma Cell Motility
Ishida Y; Shintani T; Nobumoto T; Sakurai S; Hamana T; Yanamoto S; Hayashido Y
Anticancer Res; 2023 Nov; 43(11):4833-4841. PubMed ID: 37909974
[TBL] [Abstract] [Full Text] [Related]
4. rac1 activation in oral squamous cell carcinoma as a predictive factor associated with lymph node metastasis.
Yamazaki M; Sekikawa S; Suzuki T; Ogane S; Hashimoto K; Sasaki A; Nomura T
Int J Clin Oncol; 2023 Sep; 28(9):1129-1138. PubMed ID: 37418142
[TBL] [Abstract] [Full Text] [Related]
5. Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer.
Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Dong Y; Geng Z; Zheng J; Lu X
Apoptosis; 2023 Oct; 28(9-10):1315-1331. PubMed ID: 37336836
[TBL] [Abstract] [Full Text] [Related]
6. A comprehensive signature based on endoplasmic reticulum stress-related genes in predicting prognosis and immunotherapy response in melanoma.
Liu L; Yao D; Chen Z; Duan S
Sci Rep; 2023 May; 13(1):8232. PubMed ID: 37217516
[TBL] [Abstract] [Full Text] [Related]
7. CCL2 promotes lymphatic metastasis via activating RhoA and rac1 pathway and predict prognosis to some extent in tongue cancer.
Dong Y; Zhang S; Zhao S; Xuan M; Zhu G; Zhang Z; Guo W
Cancer Biol Ther; 2023 Dec; 24(1):2205342. PubMed ID: 37132640
[TBL] [Abstract] [Full Text] [Related]
8. Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in head and neck Squamous Cell Carcinoma via the rac1/Wnt/β-catenin Pathway.
Yu BY; Shi LG; Jiang C; Wang GK; Liu J; Wu TY
Lab Invest; 2023 Jul; 103(7):100134. PubMed ID: 36990154
[TBL] [Abstract] [Full Text] [Related]
9. Loss of cell-cell adhesion triggers cell migration through rac1-dependent ROS generation.
Chen YH; Hsu JY; Chu CT; Chang YW; Fan JR; Yang MH; Chen HC
Life Sci Alliance; 2023 Feb; 6(2):. PubMed ID: 36446524
[TBL] [Abstract] [Full Text] [Related]
10. CapG promoted nasopharyngeal carcinoma cell motility involving Rho motility pathway independent of ROCK.
Fu Y; Zhang X; Liang X; Chen Y; Chen Z; Xiao Z
World J Surg Oncol; 2022 Oct; 20(1):347. PubMed ID: 36258216
[TBL] [Abstract] [Full Text] [Related]
11. Tumor pH-functionalized and charge-tunable nanoparticles for the nucleus/cytoplasm-directed delivery of oxaliplatin and miRNA in the treatment of head and neck cancer.
Lo YL; Lin HC; Tseng WH
Acta Biomater; 2022 Nov; 153():465-480. PubMed ID: 36115656
[TBL] [Abstract] [Full Text] [Related]
12. The potential diagnostic value of rac1 immunohistochemistry in follicular thyroid carcinoma.
Agustina H; Ahyati R; Suryanti S; Hernowo BS
Malays J Pathol; 2022 Aug; 44(2):225-233. PubMed ID: 36043585
[TBL] [Abstract] [Full Text] [Related]
13. Epithelial Membrane Protein 1 Promotes Sensitivity to RSL3-Induced Ferroptosis and Intensifies Gefitinib Resistance in head and neck cancer.
Wang Y; Zhang L; Yao C; Ma Y; Liu Y
Oxid Med Cell Longev; 2022; 2022():4750671. PubMed ID: 35432717
[TBL] [Abstract] [Full Text] [Related]
14. Clinical utility of PDX cohorts to reveal biomarkers of intrinsic resistance and clonal architecture changes underlying acquired resistance to cetuximab in HNSCC.
Yao Y; Wang Y; Chen L; Tian Z; Yang G; Wang R; Wang C; Wu Q; Wu Y; Gao J; Kang X; Duan S; Zhang Z; Sun S
Signal Transduct Target Ther; 2022 Mar; 7(1):73. PubMed ID: 35260570
[TBL] [Abstract] [Full Text] [Related]
15. Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma.
Ling Z; Li W; Hu J; Li Y; Deng M; Zhang S; Ren X; Wu T; Xia J; Cheng B; Tao X
Cell Death Dis; 2022 Feb; 13(2):158. PubMed ID: 35177591
[TBL] [Abstract] [Full Text] [Related]
16. Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinoma.
Amr S; Ioffe D; Suzuki I; Mehra R; Cullen K; Goloubeva O
Head Neck; 2021 Dec; 43(12):3935-3945. PubMed ID: 34632677
[TBL] [Abstract] [Full Text] [Related]
17. Oral submucous fibrosis stimulates invasion and epithelial-mesenchymal transition in oral squamous cell carcinoma by activating MMP-2 and IGF-IR.
Chen PN; Lin CW; Yang SF; Chang YC
J Cell Mol Med; 2021 Oct; 25(20):9814-9825. PubMed ID: 34528373
[TBL] [Abstract] [Full Text] [Related]
18. DNAJA1 promotes cancer metastasis through interaction with mutant p53.
Kaida A; Yamamoto S; Parrales A; Young ED; Ranjan A; Alalem MA; Morita KI; Oikawa Y; Harada H; Ikeda T; Thomas SM; Diaz FJ; Iwakuma T
Oncogene; 2021 Aug; 40(31):5013-5025. PubMed ID: 34183772
[TBL] [Abstract] [Full Text] [Related]
19. Resveratrol suppresses malignant progression of oral squamous cell carcinoma cells by inducing the ZNF750/rac1 signaling pathway.
Xiao Y; Duan Y; Wang Y; Yin X
Bioengineered; 2021 Dec; 12(1):2863-2873. PubMed ID: 34176441
[TBL] [Abstract] [Full Text] [Related]
20. Oxidative Stress-Induced Unscheduled CDK1-Cyclin B1 Activity Impairs ER-Mitochondria-Mediated Bioenergetic Metabolism.
Chang JG; Tien N; Chang YC; Lin ML; Chen SS
Cells; 2021 May; 10(6):. PubMed ID: 34064109
[TBL] [Abstract] [Full Text] [Related]
[Next]
